| Videos | Channels | Search |
From the Floor: When the new trumps the rumour... (12:47)Markets have largely batted away the black swan of a Trump victory,...
|
Quarterly outlook: Marathon bull run (04:53)The main Q4 topics for equities include the US presidential...
|
Neighbour: Shorting GSK as pharma stocks catch... (01:18)Joe Neighbour has been tracking GlaxoSmithKline, a big pharma stock...
|
Knuthsen: As Novo beats, why Danish stocks are... (02:06)The Danish large cap OMX Copenhagen 20 index has risen more than...
|
Earnings Season: GSK will disappoint but pharma... (02:29)Expect them to be disappointing. That's what Saxo's Peter Garnry...
|
Are high returns from marijuana companies just... (05:18)This week the New York Times, in an editorial, urged US lawmakers...
|
Berger: Biogen's healthy recovery (02:06)Serge Berger suggests buying Biogen, a biotech firm which has...
|
Just what is Monsanto up to? (02:11)It’s been revealed that talks between US agricultural giant...
|
Garnry: "Astra Zeneca shareholders blew it" (02:54)AstraZeneca’s stock price tumbled 14 percent on Monday morning...
|
Astra Zeneca and Pfizer: Five things you need... (00:58)As the Astra Zeneca Pfizer deal gets more bad tempered and...
|
Buying the biotech boost (02:38)Leading Bio
tech firms, have seen around thirty percent growth in...
|
Pfizer-AstraZeneca: 'Deal will likely get done' (01:28)What next in the drama surrounding the proposed merger of...
|
Switch to